FOLH1 and neoplasm: Nevertheless, the results of this investigation warrant further preclinical studies to determine whether the in vivo stability and tumor uptake of 99mTc-HscFv2 still offer sufficient advantages over HYNIC-conjugated peptides to consider it a promising agent for SPECT/PSMA imaging.